RXRX icon

Recursion Pharmaceuticals
RXRX

Overview Fund Activity

333 hedge funds and large institutions have $1.61B invested in Recursion Pharmaceuticals in 2025 Q1 according to their latest regulatory filings, with 66 funds opening new positions, 138 increasing their positions, 67 reducing their positions, and 41 closing their positions.

Holders
333
Holders Change
+21
Holders Change %
+6.73%
% of All Funds
4.52%
Holding in Top 10
9
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-10%
% of All Funds
0.12%
New
66
Increased
138
Reduced
67
Closed
41
Calls
$28.3M
Puts
$21.7M
Net Calls
+$6.56M
Net Calls Change
+$6.77M

Top Buyers

1
UBS AM
1
UBS AM
Illinois
$33.9M
2
UBS Group
2
UBS Group
Switzerland
$29.5M
3
AIM
3
ARK Investment Management
Florida
$184M
4
Morgan Stanley
4
Morgan Stanley
New York
$26.5M
5
KA
5
Kinnevik AB
Sweden
$71.1M

Top Sellers

1
RCM
1
RA Capital Management
Massachusetts
$0
2
DM
2
Deerfield Management
New York
$0
3
Vanguard Group
3
Vanguard Group
Pennsylvania
$171M
4
LCM
4
Laurion Capital Management
New York
$8.19M
5
WP
5
Woodline Partners
California
$0
Name Market Value Shares Shares
Change 		Shares
Change %
NL
26
Nuveen LLC
North Carolina
$10.1M 1,912,620 +1,912,620 New
Dimensional Fund Advisors
27
Dimensional Fund Advisors
Texas
$9.09M 1,716,775 +8,735 +0.5%
LCM
28
Laurion Capital Management
New York
$8.19M 1,547,407 -909,782 -37%
Goldman Sachs
29
Goldman Sachs
New York
$7.91M 1,495,863 -569,345 -28%
Bank of America
30
Bank of America
North Carolina
$6.8M 1,284,962 +402,098 +46%
Two Sigma Investments
31
Two Sigma Investments
New York
$6.1M 1,152,626 -507,883 -31%
First Trust Advisors
32
First Trust Advisors
Illinois
$5.46M 1,031,499 +1,031,499 New
CFM
33
Comprehensive Financial Management
California
$4.98M 941,895 – –
Bank of New York Mellon
34
Bank of New York Mellon
New York
$4.57M 863,224 +12,588 +1%
JPMorgan Chase & Co
35
JPMorgan Chase & Co
New York
$4.33M 818,324 -238,843 -23%
VAS
36
Vestmark Advisory Solutions
Massachusetts
$3.74M 706,239 -138,915 -16%
NFGH
37
Nan Fung Group Holdings
Hong Kong
$3.52M 664,610 – –
Citigroup
38
Citigroup
New York
$3.49M 659,449 +158,461 +32%
Balyasny Asset Management
39
Balyasny Asset Management
Illinois
$3.45M 652,644 +652,644 New
Wells Fargo
40
Wells Fargo
California
$3.19M 603,728 +145,407 +32%
Rafferty Asset Management
41
Rafferty Asset Management
New York
$3.17M 598,420 +2,948 +0.5%
PBPIA
42
Pivotal bioVenture Partners Investment Advisor
California
$3.15M 595,518 – –
LIP
43
Liontrust Investment Partners
United Kingdom
$3.15M 595,055 -336,672 -36%
JF
44
Jump Financial
Illinois
$3.13M 592,353 +578,859 +4,290%
Barclays
45
Barclays
United Kingdom
$3.13M 591,006 -42,119 -7%
Lazard Asset Management
46
Lazard Asset Management
New York
$2.68M 506,138 -49,712 -9%
Millennium Management
47
Millennium Management
New York
$2.66M 502,108 +473,798 +1,674%
Swiss National Bank
48
Swiss National Bank
Switzerland
$2.56M 483,300 -3,400 -0.7%
Simplex Trading
49
Simplex Trading
Illinois
$2.54M 481,048 +217,676 +83%
LPL Financial
50
LPL Financial
California
$2.25M 425,090 +57,305 +16%
1
2
3 4 5